Early CRISPR treatment showed major cholesterol reduction in just two weeks * High-dose therapy led to about a fifty percent ...

Oppenheimer emphasized the advancements in CRISPR’s in vivo initiatives, highlighting the comprehensive findings from the ...

Study at University of Cincinnati reveals why pancreatic cancer cells resist KRAS inhibitors, suggesting EGFR blocking could ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...

From 2017 until Oct. 1, 2025, sponsors have submitted around 50 INDs seeking to begin clinical testing of individualized ...

Utilizing the gene-editing technology CRISPR, researchers have found a way to combat chemoresistance in lung cancer cells, restoring hope for patients. Shannon Horning/ SciTech Editor For patients ...

One of the biggest challenges in cancer treatment is something called “drug resistance.” This happens when cancer cells stop ...

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...

Explore trends before investing – request a sample report today! In 2024, CNS gene therapy development surged, supported by ...

These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...